GlassScriptPhysician profile
Claudia S Cohn
NPI 1215194972
$34,711.44
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $3,300 · 2021: $9,975 · 2022: $77.65 · 2023: $12K · 2024: $9,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,550 · Travel and Lodging: $272 · Education: $120 · Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,550.00 |
| Travel and Lodging | $272.40 |
| Education | $120.26 |
| Food and Beverage | $116.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho-Clinical Diagnostics, INC. | $15,122.91 | 2021-2024 | Ortho |
| Fresenius Kabi USA, LLC | $10,788.53 | 2023-2024 | Amicus Separator |
| Werfen USA LLC | $5,100.00 | 2020-2021 | |
| Octapharma USA, INC. | $1,500.00 | 2020 | |
| Grifols Diagnostic Solutions, INC. | $1,000.00 | 2021 | |
| Biomerieux INC | $1,000.00 | 2021 | |
| Terumo Bct, INC. | $200.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.